PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma

Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, "Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States"

Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma
2021-03-22
(Press-News.org) Oncotarget published "Predictors of immunotherapy benefit in Merkel cell carcinoma" which reported that the authors retrospectively analyzed electronic health records and next-generation sequencing data of 45 patients treated at our institution from 2013 to 2020 to understand clinical and genomic correlates of benefit from immunotherapy.

They reported that their cohort predominantly included individuals with stage III disease at primary disease diagnosis and individuals with stage IV disease at recurrent/metastatic disease diagnosis.

Less advanced stages at primary disease diagnosis and shorter disease-free interval between completion of initial treatment and recurrence were each associated with greater odds of response.

Single-nucleotide variants in ARID2 and NTRK1 were associated with response, while none of Merkel cell polyomavirus status, total mutational burden, ultraviolet mutational signatures, and copy-number alterations predicted outcomes.

Patients with shorter disease-free intervals may be particularly suitable immunotherapy candidates.

Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, "Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States."

Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, "Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States" Before the age of immunotherapy, there was significant room for improvement in survival rates, with five-year survival of 60% overall and 14–21% among patients with distant disease.

Now, immune checkpoint inhibitors in the metastatic setting are associated with often durable response rates approaching 70% and three-year overall survival of up to 64%.

However, knowledge of predictors of response is lacking. Clinicians require a greater understanding of predictive markers for therapy selection, while researchers require an improved understanding of underlying mechanisms to inform drug development and trial design.

In the present study, the authors build on this prior approach by incorporating multivariable analysis techniques, studying patients over a longer follow-up time period, and by studying a homogeneous MCC population all treated with CPIs.

Additionally, they set out to include a greater number of CPI-treated patients in their work and statistically analyze the correlations of specific single nucleotide variants and copy number variations with response to CPIs.

The Hanna Research Team concluded in their Oncotarget Research Output, "Our study points to several factors for clinicians to consider in the context of other clinical and pathologic findings when making treatment decisions. In particular, patients with ARID2 mutations, NTRK1 mutations, or shorter time to recurrence may be expected to have a higher likelihood of benefit from CPIs. These findings present potential areas for future basic scientific research related to molecular mechanisms. Future clinical study may explore the potential for Trk inhibition in combination or sequence with immunotherapies."

INFORMATION:

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27823

Full text - https://www.oncotarget.com/article/27823/text/

Correspondence to - Glenn J. Hanna - glenn_hanna@dfci.harvard.edu

Keywords - cancer, genomics, immunotherapy, Merkel cell carcinoma, precision medicine

About Oncotarget

Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105


[Attachments] See images for this press release:
Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma

ELSE PRESS RELEASES FROM THIS DATE:

Oncotarget: Hispanic Chronic myelomonocytic leukemia patients

Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
2021-03-22
Oncotarget published "Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico" which reported that one hundred and eleven Hispanic CMML patients from Puerto Rico were diagnosed in our institute from 2009 to 2018. Karyotypes were available in one hundred and seven patients. Compared to previously published data, Hispanic CMML patients in this study had significantly lower rates of overall cytogenetic abnormalities and trisomy 8. Among one hundred and eleven Hispanic CMML patients, 40-gene myeloid molecular profile tests were performed in fifty-six CMML patients. Previous studies indicated that mutated ASXL1, DNMT3A, NRAS, RUNX1, and SETBP1 may associate with an unfavorable prognosis ...

Oncotarget: Ibuprofen disrupts protein complex in colorectal cells

Oncotarget: Ibuprofen disrupts protein complex in colorectal cells
2021-03-22
Oncotarget published "Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells" which reported that although the molecular mechanism behind the antitumor properties of NSAIDs has been largely attributed to inhibition of cyclooxygenases , several studies have shown that the chemopreventive properties of ibuprofen also involve multiple COX-independent effects. One example is its ability to inhibit the alternative splicing event generating RAC1B, which is overexpressed in a specific subset ...

Aging-US: Aging and rejuvenation - a modular epigenome model

Aging-US: Aging and rejuvenation - a modular epigenome model
2021-03-22
Aging-US published "Aging and rejuvenation - a modular epigenome model" which reported that the view of aging has evolved in parallel with the advances in biomedical sciences. Long considered as an irreversible process where interventions were only aimed at slowing down its progression, breakthrough discoveries like animal cloning and cell reprogramming have deeply changed our understanding of postnatal development, giving rise to the emerging view that the epigenome is the driver of aging. The idea was significantly strengthened by the converging discovery that DNA methylation at specific CpG sites could be used as a highly accurate biomarker of age defined by an algorithm known as the Horvath clock (also published in Aging-US here). It was at this point ...

Virtual lab finds the right AI tool for each chemistry problem

2021-03-22
Having the right tool for the job makes the job a lot easier, less expensive and faster. Chemical engineering researchers have now developed a virtual laboratory that can be used to determine the artificial intelligence (AI) tools best suited for addressing various chemical synthesis challenges in flow chemistry systems. "Autonomous systems have tremendous potential for accelerating chemical R&D and manufacturing, but they are not in widespread use yet," says Milad Abolhasani, corresponding author of a paper on the work and an assistant professor of chemical engineering at North Carolina State University. "These systems face two kinds of ...

A project by Russian scientists will help create capsules for targeted drug delivery

A project by Russian scientists will help create capsules for targeted drug delivery
2021-03-22
Scientists from MIPT and ITMO University and their colleagues have studied the formation and growth of crystals from simple organic molecules into large associations. These experiments will help create capsules for targeted drug delivery to specific tissues in the human body. The scientific paper was published in the journal Crystal Growth & Design. Melamine cyanurate consists of melamine, colourless crystals, and cyanuric acid, whose molecules associate in a similar way to DNA formation. The various studies associated with it could be useful ...

Predicting who may do best with psychedelic-assisted therapy

2021-03-22
COLUMBUS, Ohio - As psychedelics gain ground as a potential therapy for mental health disorders, there remains a pressing concern that patients in clinical trials may have adverse effects to the drugs. New research identifies personality traits that have been associated with positive and negative experiences on psychedelics in previous studies, information that could help predict how future clinical trial participants will respond to the drugs. The findings suggest that people more open to new experiences and willing to surrender to the unknown may be best positioned to have a positive experience on psychedelics, and individuals who tend to be preoccupied or apprehensive could be more likely to have a ...

Pandemic lockdowns boost, democratize online education

2021-03-22
ITHACA, N.Y. - As the COVID-19 pandemic took hold in 2020, the list of things people could not do grew increasingly long. But while going to the office, attending live events and gathering with large groups of friends became difficult or impossible, other activities grew in popularity - including online learning. Drawing on records from DataCamp, an online platform tailored toward programming skills, a research team at Cornell University and Arizona State University used U.S. states' staggered adoption of nonessential business closures (NBC) to estimate their effects on the demand for online learning. The gradual closure of businesses across the U.S. gave the researchers a way to make a case for the cause and effect of NBC on increased engagement with the DataCamp ...

Aging-US: Adiposity & Muscle Function: a community-based cross-sectional study

Aging-US: Adiposity & Muscle Function: a community-based cross-sectional study
2021-03-22
Aging-US published "Impact of adiposity on muscle function and clinical events among elders with dynapenia, presarcopenia and sarcopenia: a community-based cross-sectional study" which reported that low muscle function determined unfavorable clinical outcome than low muscle mass; nevertheless, comparison of detrimental parameters among dynapenia, presarcopenia and sarcopenia was sparse. The authors hypothesized that adiposity is implicated in low muscle function related adverse events. Associations of different obesity parameters, metabolic syndrome and fall among the groups were analyzed. Among 765 participants, ...

Cancer study highlights racial disparities for patients facing dual diagnoses

2021-03-22
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection. After reviewing detailed information from almost 5,000 patients with active or past cancer and laboratory-confirmed COVID-19 diagnosis, CCC19 study authors found associations among laboratory measures, clinical factors -- including older age, hematological malignancy and recent chemotherapy - and poor clinical outcomes. Of the patients in the study with COVID-19 ...

Aging-US: Aging phenotype of MDPL syndrome associated with impaired DNA repair capacity

Aging-US: Aging phenotype of MDPL syndrome associated with impaired DNA repair capacity
2021-03-22
Aging-US published "Functional analysis of POLD1 p.ser605del variant: the aging phenotype of MDPL syndrome is associated with an impaired DNA repair capacity" which reported that Mandibular hypoplasia, Deafness and Progeroid features with concomitant Lipodystrophy define a rare systemic disorder, named MDPL Syndrome, due to almost always a de novo variant in POLD1 gene, encoding the DNA polymerase δ. A decline of cell growth, cellular senescence and a blockage of proliferation in G0/G1 phase complete the aged cellular picture. Moreover, the rate of telomere shortening was greater in pathological ...

LAST 30 PRESS RELEASES:

MIT Press’s Direct to Open reaches annual funding goal for 2025, opens access to 80 new monographs

New NCCN patient resource shares latest understanding of genetic testing to guide patient decision making

Synchronization in neural nets: Mathematical insight into neuron readout drives significant improvements in prediction accuracy

TLE6 identified as a protein associated with infertility in male mice

Thin lenses have a bright future

Volcanic eruption caused Neolithic people to sacrifice unique "sun stones"

Drug in clinical trials for breast cancer could also treat some blood cancers

Study identifies mechanism underlying increased osteoarthritis risk in postmenopausal females

The material revolution: How USA’s commodity appetite evolved from 1900 to present

Asteroid impact sulfur release less lethal in dinosaur extinction

Study shows seed impact mills clobber waterhemp seed viability

Study links rising suicidality among teen girls to increase in identifying as LGBQ

Mind’s eye: Pineal gland photoreceptor’s 2 genes help fish detect color

Nipah virus: epidemiology, pathogenesis, treatment, and prevention

FDA ban on Red Dye 3 and more are highlighted in Sylvester Cancer's January tip sheet

Mapping gene regulation

Exposure to air pollution before pregnancy linked to higher child body mass index, study finds

Neural partially linear additive model

Dung data: manure can help to improve global maps of herbivore distribution

Concerns over maternity provision for pregnant women in UK prisons

UK needs a national strategy to tackle harms of alcohol, argue experts

Aerobic exercise: a powerful ally in the fight against Alzheimer’s

Cambridge leads first phase of governmental project to understand impact of smartphones and social media on young people

AASM Foundation partners with Howard University Medical Alumni Association to provide scholarships

Protective actions need regulatory support to fully defend homeowners and coastal communities, study finds

On-chip light control of semiconductor optoelectronic devices using integrated metasurfaces

America’s political house can become less divided

A common antihistamine shows promise in treating liver complications of a rare disease complication

Trastuzumab emtansine improves long-term survival in HER2 breast cancer

Is eating more red meat bad for your brain?

[Press-News.org] Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma
Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, "Merkel cell carcinoma (MCC) is a relatively rare cancer, with roughly 400 cases per 100,000 persons each year in the United States"